WO2025248370 - COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND METHYLGLYOXAL
National phase entry is expected:
Publication Number
WO/2025/248370
Publication Date
04.12.2025
International Application No.
PCT/IB2025/055053
International Filing Date
14.05.2025
Title **
[English]
COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND METHYLGLYOXAL
[French]
COMPOSITIONS, SYSTÈMES ET MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE DE CHAMPS DE TRAITEMENT TUMORAL ET DE MÉTHYLGLYOXAL
Applicants **
NOVOCURE GMBH
Inventors
SCHEER, Maximilian
Priority Data
63/654,408
31.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2162 | |
| EPO | Filing, Examination, Granting | 8695 | |
| Japan | Filing, Examination, Granting | 2172 | |
| South Korea | Filing, Examination, Granting | 2039 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
21,008
Contact Us
Abstract[English]
Compositions, systems, and methods for reducing viability of cancer cells and treating cancer, as well as preventing an increase of volume of a tumor present in a body of a living subject, are disclosed. Also disclosed are methods of enhancing cytotoxicity of MGO against cancer cells. The systems and methods involve application of an alternating field in combination with administration of at least one composition comprising methylglyoxal (MGO).[French]
Des compositions, des systèmes et des méthodes pour réduire la viabilité de cellules cancéreuses et traiter le cancer, ainsi que pour prévenir une augmentation du volume d'une tumeur présente dans le corps d'un patient vivant sont divulgués. L'invention concerne également des procédés d'amélioration de la cytotoxicité de méthylglyoxal (MGO) contre des cellules cancéreuses. Les systèmes et les procédés impliquent l'application d'un champ alternatif en combinaison avec l'administration d'au moins une composition contenant du MGO.